Trial
NCT04258150
Ipilimumab, Nivolumab, Tocilizumab and Radiation in Pretreated Patients With Advanced Pancreatic Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Herlev Hospital
Collaborators
—
Condition
Pancreatic Cancer
Intervention
Nivolumab
Why stopped
primary endpoint was not met
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-31